New registry tracks Drug-Coated Balloon's Real-World performance in chinese heart patients
NCT ID NCT04085445
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed registry study followed 500 Chinese patients who received the Agent DCB, a paclitaxel-coated balloon catheter, during a heart procedure to open blocked arteries. The goal was to collect real-world data on heart-related events like heart attacks or repeat procedures over 12 months. The study did not test a new treatment but rather observed outcomes in routine practice.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
paclitaxel-coated balloon catheter
What this could lead to
If successful, this registry could provide real-world evidence on how well the Agent DCB balloon works for treating blocked heart arteries in Chinese patients.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove cause and effect. Results may not apply to other populations or devices.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cheng Hsin General Hospital
Taipei, Taiwan
-
China Medical University Hospital
Taichung, Taiwan
-
Hualien Tzu Chi Hospital
Hualien City, 970, Taiwan
-
Kaohsiung Veterans General Hospital
Kaohsiung City, Taiwan
-
Mackay Memorial Hospital
Taipei, Taiwan
-
National Taiwan University Hospital
Taipei, Taiwan
-
Queen Mary Hospital
Hong Kong, Hong Kong
-
Taipei Veterans General Hospital
Taipei, Taiwan
-
Tan Tock Seng Hospital
Singapore, Singapore